Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Dumping Cronos Group Stock Is a Big Mistake

By Chris Lau, InvestorPlace Contributor

Altria invested big in Cronos but the stock faded in the months that followed. With all that cash on hand, CRON stock is ready to grow.

7 High-Yielding Dividend Stocks to Buy for the Next Decade

By Chris Lau, InvestorPlace Contributor

Falling interest rates will give high-yielding dividend stocks a boost in the coming decade. Here are seven names to buy.

Why It’s Time to Buy the Dip in Amazon.com Stock

By Chris Lau, InvestorPlace Contributor

Amazon.com stock is down by over 11% from 52-week highs. AMZN stock investors fear short-term investments will not pay off.

When Exactly Will Aurora Cannabis Stock’s Downtrend End?

By Chris Lau, InvestorPlace Contributor

Disappointing earnings from CannTrust Holdings and regulatory violations from Tilray hurt Aurora Cannabis stock. Investors must decide if it's time to buy or hold on this dip.

Why Investors Should Trade Cautiously With Hexo Stock

By Chris Lau, InvestorPlace Contributor

Markets are avoiding cannabis stocks, taking Hexo stock lower. What does it take to win back investors when it reports next month?

8 Biotech Stocks to Watch After the Q2 Earnings Season

By Chris Lau, InvestorPlace Contributor

Uncertainty is a constant risks for biotech stocks. Which ones matter? Some are down so much investors cannot ignore them now.

AMD Stock’s Post-Earnings Recovering Shows Investor Optimism

By Chris Lau, InvestorPlace Contributor

AMD stock barely fell after reporting lower revenue. Investors are optimistic about AMD's prospects over the next few years.

NIO Could Be Worth Betting on at Below $3

By Chris Lau, InvestorPlace Contributor

Bears locked on the weak July delivery numbers NIO posted. August delivery numbers will rise. Plus, a better earnings report is possible.

After Another Strong Quarter, Alibaba Stock Will Reward Long-Term Investors

By Chris Lau, InvestorPlace Contributor

Alibaba stock reported a strong quarter, as usual. Markets will not react in the short term but those accumulating BABA will be rewarded.

Investors Shouldn’t Worry About Canopy Growth Stock’s Weak Q1

By Chris Lau, InvestorPlace Contributor

CGC stock sank after its last quarterly earnings report. Its first-quarter report will not impress investors either.

Load More